glp-1 and gip receptor agonist Potential Use of GIP/GLP-1 Agonists for Respiratory Disorders: Where Are We at? Dual GIP/GLP-1 receptor agonists: New

ESM Fig 2)

Effect of truncated glucagonlike peptide1 [proglucagon(78107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach

The complex interaction of factors such as insulin resistance, glucotoxicity and lipotoxicity contribute to the pathogenesis and coexistence of diabetes and metabolic-dysfunction associated steatotic liver disease (MASLD) in a reciprocal process of exacerbating the underlying conditions [9]

Besides, in H9c2 cardiomyocytes, GLP-1RAs also inhibit hypoxia-induced NLRP3 inflammasome activity and TNF- to attenuate pyroptosis through modulating the SIRT1/NADPH oxidase 4 (NOX4)/ROS pathway [139]

Evaluate projects that Pfizer will further drop in the rankings to fifth place by 2030

Furthermore, combination therapy trials exploring the synergistic effects of GLP-1RAs with biologics could uncover new approaches for treatment, enhancing the management both metabolic and immunologic aspects in PsA